To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ISY1andRAB43TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
531 supporting clones for gene ISY1andRAB43 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AB032986 brain .a 1 to 4868 1 to 4869 exact tiling clone, available from KIAA,   4869/4869
(100 %)
9 diff
(99.9 %id)
BF307789 muscle, rhabdomyosarcoma .a 74 to 724 1 to 653       653/920
(70 %)
29 diff
(96.9 %id)
BF306775 muscle, rhabdomyosarcoma .a 74 to 724 1 to 648       648/928
(69 %)
26 diff
(97.2 %id)
BI114000 muscle, rhabdomyosarcoma .a 74 to 573 1 to 504       500/659
(75 %)
13 diff
(98.1 %id)
BE728600 melanotic melanoma, skin .a 77 to 867 1 to 790       788/851
(92 %)
27 diff
(96.9 %id)
BG749406 eye, normal pigmented retinal epithelium .a 92 to 724 1 to 636       636/649
(97 %)
8 diff
(98.8 %id)
BE295520 muscle, rhabdomyosarcoma .a 94 to 686 1 to 596       596/629
(94 %)
12 diff
(98.1 %id)
BE296803 muscle, rhabdomyosarcoma .a 94 to 724 1 to 629       629/630
(99 %)
11 diff
(98.3 %id)
BP225068   .a 96 to 683 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
N56159   .a 114 to 364 1 to 251       251/294
(85 %)
10 diff
(96.6 %id)
AI906733 breast .a 130 to 189 63 to 4       60/63
(95 %)
0 diff
(100 %id)
BM018748 astrocytoma grade IV, cell line, brain .a 141 to 595 1 to 457       457/834
(54 %)
7 diff
(99.2 %id)
BI222532 cervical carcinoma cell line, cervix .a 142 to 798 16 to 675       660/676
(97 %)
9 diff
(98.7 %id)
TI_59389417   .a 142 to 595 108 to 563       456/833
(54 %)
6 diff
(99.3 %id)
BI117508 lung, small cell carcinoma .a 179 to 664 1 to 487       487/584
(83 %)
7 diff
(98.9 %id)
BE207207 lung, small cell carcinoma .a 181 to 565 1 to 385       385/385
(100 %)
6 diff
(98.5 %id)
BE896132 melanotic melanoma, skin .a 194 to 945 1 to 740       740/954
(77 %)
22 diff
(97.7 %id)
AA247242   .a 198 to 457 1 to 258       258/258
(100 %)
8 diff
(96.9 %id)
BQ638762 eye, retina .a 204 to 782 36 to 615       580/615
(94 %)
8 diff
(98.7 %id)
T31146 brain .a 221 to 479 10 to 268       259/280
(92 %)
7 diff
(97.5 %id)
BP331077 rectum .a 231 to 816 1 to 582       586/582
(100 %)
9 diff
(98.5 %id)
CN349151 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 257 to 889 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
BE382910 brain, neuroblastoma .a 267 to 807 1 to 541       541/541
(100 %)
0 diff
(100 %id)
BP330284 rectum .a 282 to 867 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
BF082056 breast_normal .a 285 to 804 529 to 9       521/529
(98 %)
6 diff
(98.9 %id)
BF807430 colon_ins .a 303 to 717 1 to 415       415/415
(100 %)
2 diff
(99.6 %id)
Z21170   .a 311 to 596 1 to 286       286/286
(100 %)
0 diff
(100 %id)
BF958819 nervous_normal .a 322 to 721 401 to 2       400/401
(99 %)
0 diff
(100 %id)
BM845865 myeloma .a 359 to 693 1 to 334       334/334
(100 %)
3 diff
(99.2 %id)
BF219669 esophageal squamous cell carcinoma .a 522 to 654 133 to 1       133/133
(100 %)
0 diff
(100 %id)
AI940176 colon .a 548 to 762 1 to 215       215/215
(100 %)
3 diff
(98.7 %id)
AI940191 colon .a 550 to 762 1 to 213       213/213
(100 %)
0 diff
(100 %id)
CR999596.
matches multiple genes
T-Lymphocytes .a 931 to 1403 1 to 476     also hits gene rasuma 476/478
(99 %)
4 diff
(99.2 %id)
CN349143.
matches multiple genes
embryonic stem cells, cell lines H1, H7, andH9 .a 991 to 1104 1 to 114     also hits gene rasuma 114/114
(100 %)
0 diff
(100 %id)
CN349149.
matches multiple genes
embryonic stem cells, cell lines H1, H7, andH9 .a 1009 to 1628 1 to 621     also hits gene rasuma 621/626
(99 %)
6 diff
(99.1 %id)
CR998305.
matches multiple genes
T-Lymphocytes .a 1012 to 1690 1 to 681     also hits gene rasuma 681/682
(99 %)
5 diff
(99.3 %id)
CR976100.
matches multiple genes
T-Lymphocytes .a 1093 to 1696 1 to 605     also hits gene rasuma 605/607
(99 %)
5 diff
(99.2 %id)
DN999909.
matches multiple genes
  .a 1147 to 1686 9 to 549     also hits gene rasuma 541/549
(98 %)
6 diff
(99.0 %id)
BM459050 melanotic melanoma, skin .a 1152 to 1951 1 to 802   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 802/802
(100 %)
3 diff
(99.7 %id)
BQ307837 breast .a 1166 to 1377 12 to 219       208/219
(94 %)
9 diff
(95.9 %id)
CN349144 embryonic stem cells, DMSO-treated H9 cellline .a 1197 to 1841 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
BM150802.
matches multiple genes
leukopheresis .a 1210 to 1735 1 to 527     also hits gene rasuma 527/527
(100 %)
6 diff
(98.9 %id)
DA716930.
matches multiple genes
  .a 1214 to 1757 2 to 545   capped also hits gene rasuma 544/544
(100 %)
1 diff
(99.9 %id)
DA716936.
matches multiple genes
  .a 1214 to 1766 2 to 554   capped also hits gene rasuma 553/553
(100 %)
1 diff
(99.9 %id)
BU607510 Human Lung Epithelial cells, lung .a 1222 to 1953 744 to 17   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 728/732
(99 %)
7 diff
(99.1 %id)
BI519805.
matches multiple genes
leukocyte .a 1232 to 1900 677 to 5     also hits gene rasuma 673/677
(99 %)
0 diff
(100 %id)
TI_44460234.
matches multiple genes
  .a 1232 to 1900 677 to 5     also hits gene rasuma 673/677
(99 %)
0 diff
(100 %id)
BU620728 cell lines, Chondrosarcoma .a 1239 to 1951 731 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 713/713
(100 %)
1 diff
(99.9 %id)
CA307619 Alveolar Macrophage, lung .a 1306 to 1951 661 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 643/643
(100 %)
6 diff
(99.1 %id)
BF887376.
matches multiple genes
testis_normal .a 1381 to 1733 371 to 24     Submitted on the opposite strand, also hits gene rasuma 348/371
(93 %)
0 diff
(100 %id)
DA390968.
matches multiple genes
thalamus .a 1393 to 1984 2 to 593   capped also hits gene rasuma 592/592
(100 %)
1 diff
(99.9 %id)
BU620371 cell lines, Chondrosarcoma .a 1404 to 1951 567 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 549/549
(100 %)
5 diff
(99.1 %id)
AI858067 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1444 to 1952 509 to 1       509/509
(100 %)
5 diff
(99.1 %id)
CN349150.
matches multiple genes
embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1455 to 1915 1 to 461     also hits gene rasuma 461/461
(100 %)
1 diff
(99.8 %id)
AI656860.
matches multiple genes
pooled germ cell tumors .a 1472 to 1953 489 to 8     also hits gene rasuma 482/489
(98 %)
0 diff
(100 %id)
AW594317.
matches multiple genes
pooled germ cell tumors .a 1513 to 1953 448 to 8     also hits gene rasuma 441/448
(98 %)
0 diff
(100 %id)
AI076211.
matches multiple genes
B-cell, chronic lymphotic leukemia .a 1548 to 1952 405 to 1   tiling clone, also hits gene rasuma 405/405
(100 %)
1 diff
(99.8 %id)
AI280709.
matches multiple genes
poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 1551 to 1952 402 to 1     also hits gene rasuma 402/402
(100 %)
1 diff
(99.8 %id)
AA917938 Kidney .a 1556 to 1953 410 to 14   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 397/397
(100 %)
3 diff
(99.3 %id)
AA100134 Pancreas .a 1561 to 1944 392 to 6     Submitted on the opposite strand 387/392
(98 %)
0 diff
(100 %id)
BX479829.
matches multiple genes
  .a 1586 to 2011 1 to 427   tiling clone, also hits gene rasuma 427/427
(100 %)
2 diff
(99.6 %id)
AW450194.
matches multiple genes
  .a 1591 to 1951 378 to 18   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base), also hits gene rasuma 361/361
(100 %)
1 diff
(99.8 %id)
CO401794 Chondrosarcoma Lung Metastasis cell lines, lung .a 1608 to 2353 1 to 732       732/838
(87 %)
21 diff
(97.5 %id)
AI695674 Kidney .a 1611 to 1951 349 to 9       341/349
(97 %)
0 diff
(100 %id)
BU949508.
matches multiple genes
Pancreas, Purified pancreatic islet .a 1635 to 1951 16 to 332   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base), also hits gene rasuma 317/332
(95 %)
6 diff
(98.2 %id)
BU949264.
matches multiple genes
Pancreas, Purified pancreatic islet .a 1673 to 1950 278 to 1   fully sequenced, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base), also hits gene rasuma 278/278
(100 %)
2 diff
(99.3 %id)
DA126812 cerebellum .a 1699 to 2279 2 to 582   capped   581/582
(99 %)
3 diff
(99.5 %id)
AW090415 brain, tumor, 5 pooled (see description) .a 1705 to 1951 247 to 1       247/247
(100 %)
0 diff
(100 %id)
AA861576.
matches multiple genes
  .a 1706 to 1952 249 to 3     also hits gene rasuma 247/249
(99 %)
0 diff
(100 %id)
DA282773 corpus callosum .a 1810 to 2370 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
CO404676 Chondrosarcoma Lung Metastasis cell lines, lung .a 1865 to 2413 38 to 575       538/723
(74 %)
12 diff
(98.4 %id)
DB133913 thymus .a 1899 to 2437 2 to 540   capped   539/539
(100 %)
1 diff
(99.9 %id)
DB150706 thymus .a 1899 to 2377 2 to 480   capped   479/484
(98 %)
2 diff
(99.6 %id)
AL043993 testis .a 2098 to 2605 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
CX759848 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2209 to 2861 1 to 653   tiling clone, Submitted on the opposite strand 653/653
(100 %)
2 diff
(99.7 %id)
BI062381.
matches multiple genes
uterus_tumor .a 2296 to 2970 676 to 2     also hits gene RAB43P1 675/679
(99 %)
0 diff
(100 %id)
BQ949124.
matches multiple genes
sciatic nerve .a 2296 to 3060 1 to 772   tiling clone, also hits gene RAB43P1 772/904
(85 %)
36 diff
(96.1 %id)
CB989927.
matches multiple genes
Human Placenta, placenta .a 2461 to 2939 22 to 500     also hits gene RAB43P1 479/526
(91 %)
9 diff
(98.3 %id)
BE871932.
matches multiple genes
adenocarcinoma, colon .a 2535 to 3298 1 to 757     also hits gene RAB43P1 757/942
(80 %)
34 diff
(96.4 %id)
BP424845.
matches multiple genes
small intestine .a 2767 to 3266 1 to 500   tiling clone, Submitted on the opposite strand, also hits gene RAB43P1 500/500
(100 %)
2 diff
(99.6 %id)
DA694872.
matches multiple genes
  .a 2814 to 3278 2 to 466   capped also hits gene RAB43P1 465/465
(100 %)
1 diff
(99.8 %id)
CN349154.
matches multiple genes
embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2942 to 3467 1 to 526     also hits gene RAB43P1 526/526
(100 %)
1 diff
(99.9 %id)
BE280644 choriocarcinoma, placenta .a 2989 to 3655 1 to 666       666/714
(93 %)
28 diff
(96.1 %id)
BF855427.
matches multiple genes
prostate_normal .a 3049 to 3409 359 to 1     Submitted on the opposite strand, also hits gene RAB43P1 359/359
(100 %)
5 diff
(98.7 %id)
AL041235.
matches multiple genes
testis .a 3139 to 3547 1 to 410     also hits gene RAB43P1 410/410
(100 %)
2 diff
(99.6 %id)
BQ956064.
matches multiple genes
large cell carcinoma, lung .a 3179 to 4031 13 to 874   tiling clone, also hits gene RAB43P1 862/960
(89 %)
21 diff
(97.9 %id)
BQ923024.
matches multiple genes
large cell carcinoma, lung .a 3180 to 3665 1 to 485     also hits gene RAB43P1 485/1127
(43 %)
9 diff
(99.3 %id)
BI861984.
matches multiple genes
breast, mammary adenocarcinoma, cell line .a 3230 to 3745 1 to 516     also hits gene RAB43P1 516/519
(99 %)
1 diff
(99.9 %id)
TI_57193572.
matches multiple genes
  .a 3230 to 3745 27 to 542     also hits gene RAB43P1 516/519
(99 %)
1 diff
(99.9 %id)
BF924516.
matches multiple genes
nervous_tumor .a 3278 to 3574 8 to 304     also hits gene RAB43P1 297/304
(97 %)
6 diff
(98.1 %id)
H43491.
matches multiple genes
breast .a 3282 to 3718 1 to 437     also hits gene peyraw, RAB43P1 437/439
(99 %)
14 diff
(96.9 %id)
CR607147 Placenta Cot 25-normalized .a 3295 to 4841 1 to 1547   tiling clone,   1547/1547
(100 %)
0 diff
(100 %id)
BX355758.
matches multiple genes
Placenta Cot 25-normalized .a 3295 to 3970 1 to 664   fully sequenced, also hits gene RAB43P1 664/664
(100 %)
6 diff
(99.1 %id)
BC073812 Eye, normal, pigmented retinal epithelium .a 3343 to 4868 1 to 1527   available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1527/1527
(100 %)
2 diff
(99.9 %id)
BM019478.
matches multiple genes
astrocytoma grade IV, cell line, brain .a 3597 to 4269 1 to 674     also hits gene RAB43P1 674/675
(99 %)
26 diff
(96.2 %id)
TI_59390164.
matches multiple genes
  .a 3598 to 4269 121 to 793     also hits gene RAB43P1 673/674
(99 %)
26 diff
(96.2 %id)
BG323504.
matches multiple genes
Kidney, renal cell adenocarcinoma .a 3718 to 4336 1 to 612     also hits gene RAB43P1 612/631
(96 %)
19 diff
(97.0 %id)
BQ084211.
matches multiple genes
stomach .a 3870 to 4183 1 to 314     also hits gene RAB43P1 314/314
(100 %)
4 diff
(98.8 %id)
BQ084277.
matches multiple genes
stomach .a 3870 to 4093 1 to 224     also hits gene RAB43P1 224/224
(100 %)
1 diff
(99.6 %id)
BM825702.
matches multiple genes
stomach .a 3870 to 4206 1 to 337     also hits gene RAB43P1 337/337
(100 %)
0 diff
(100 %id)
BM830733.
matches multiple genes
stomach .a 3870 to 4312 1 to 443     also hits gene RAB43P1 443/443
(100 %)
2 diff
(99.6 %id)
CF126091 Chondrosarcoma Lung Metastasis cell lines, lung .a 3882 to 4609 1 to 729       729/729
(100 %)
2 diff
(99.8 %id)
TI_154188929   .a 3882 to 4819 51 to 978       928/996
(93 %)
19 diff
(98.1 %id)
BF082456.
matches multiple genes
breast .a 3889 to 4096 32 to 234     also hits gene RAB43P1 203/234
(86 %)
6 diff
(97.5 %id)
CN349148 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3894 to 4474 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BG337277 leiomyosarcoma cell line, uterus .a 3903 to 4826 1 to 924       924/926
(99 %)
31 diff
(96.7 %id)
BX355757.
matches multiple genes
Placenta Cot 25-normalized .a 3940 to 4841 887 to 1   fully sequenced, also hits gene RAB43P1 887/887
(100 %)
8 diff
(99.1 %id)
TI_149302867   .a 3961 to 4868 988 to 81   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 908/997
(91 %)
5 diff
(99.5 %id)
BM719213.
matches multiple genes
eye, fetal eye .a 3991 to 4474 1 to 485     also hits gene RAB43P1 485/485
(100 %)
2 diff
(99.6 %id)
AL041236 testis .a 3994 to 4853 859 to 1     Submitted on the opposite strand 859/859
(100 %)
2 diff
(99.8 %id)
TI_227715481   .a 4020 to 4870 918 to 83       836/1066
(78 %)
0 diff
(100 %id)
H79597.
matches multiple genes
liver and spleen .a 4027 to 4373 1 to 346     also hits gene peyraw, RAB43P1 346/346
(100 %)
8 diff
(97.7 %id)
AA044670 uterus .a 4043 to 4388 1 to 346   fully sequenced,   346/346
(100 %)
5 diff
(98.6 %id)
TI_159723400   .a 4120 to 4868 825 to 76   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 750/969
(77 %)
5 diff
(99.5 %id)
CA450364 Human Lung Epithelial cells, lung .a 4160 to 4873 732 to 19   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 714/714
(100 %)
2 diff
(99.8 %id)
CD366614 Alveolar Macrophage, lung .a 4160 to 4870 727 to 17       711/727
(97 %)
0 diff
(100 %id)
BM713599 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4197 to 4412 1 to 216   fully sequenced, Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 216/216
(100 %)
1 diff
(99.6 %id)
BM714630.
matches multiple genes
eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4197 to 4481 1 to 285     also hits gene RAB43P1 285/285
(100 %)
1 diff
(99.7 %id)
CA314919 Human Lung Epithelial cells, lung .a 4210 to 4868 677 to 16   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 662/662
(100 %)
7 diff
(99.0 %id)
TI_154132335   .a 4231 to 4870 762 to 125       638/762
(83 %)
0 diff
(100 %id)
BQ447643 Knee, Osteoarthritic Cartilage .a 4281 to 4868 605 to 16   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 590/590
(100 %)
4 diff
(99.4 %id)
BE736242 adenocarcinoma, Pancreas .a 4283 to 4866 1 to 585       585/585
(100 %)
5 diff
(99.2 %id)
AL043994 testis .a 4321 to 4861 541 to 1       541/541
(100 %)
0 diff
(100 %id)
TI_157609001   .a 4349 to 4870 609 to 88       522/610
(85 %)
0 diff
(100 %id)
AA043496 uterus .a 4358 to 4868 505 to 1   fully sequenced,   505/505
(100 %)
4 diff
(99.3 %id)
AI199567 anaplastic oligodendroglioma, brain .a 4374 to 4870 498 to 2       497/498
(99 %)
0 diff
(100 %id)
BU739619 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4382 to 4868 501 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 486/486
(100 %)
0 diff
(100 %id)
AW129926 Kidney, renal cell tumor .a 4384 to 4868 485 to 1       485/485
(100 %)
0 diff
(100 %id)
EC546298 Prostate .a 4415 to 4526 1 to 111       111/111
(100 %)
1 diff
(99.1 %id)
AW513174 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4425 to 4868 444 to 1       444/444
(100 %)
0 diff
(100 %id)
AI078716 senescent fibroblast .a 4426 to 4870 450 to 5       446/450
(99 %)
0 diff
(100 %id)
AW516902 cervix .a 4426 to 4868 443 to 1       443/443
(100 %)
0 diff
(100 %id)
BE046201.
matches multiple genes
follicular carcinoma, thyroid .a 4427 to 4871 448 to 3     also hits gene peyraw 446/448
(99 %)
0 diff
(100 %id)
AW467738.
matches multiple genes
myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 4434 to 4865 432 to 1     also hits gene peyraw 432/432
(100 %)
2 diff
(99.6 %id)
AI696821 adenocarcinoma, Pancreas .a 4447 to 4868 422 to 1       422/422
(100 %)
0 diff
(100 %id)
H42502.
matches multiple genes
breast .a 4451 to 4856 408 to 1     also hits gene peyraw, RAB43P1 408/408
(100 %)
7 diff
(98.3 %id)
H79598.
matches multiple genes
liver and spleen .a 4462 to 4867 420 to 1     also hits gene peyraw, RAB43P1 420/420
(100 %)
22 diff
(94.8 %id)
AA642722.
matches multiple genes
normal prostate, Prostate .a 4489 to 4868 378 to 1     also hits gene peyraw, RAB43P1 378/378
(100 %)
10 diff
(97.4 %id)
AA448116.
matches multiple genes
  .a 4505 to 4854 1 to 351   fully sequenced, also hits gene peyraw 351/351
(100 %)
3 diff
(99.2 %id)
DB538053.
matches multiple genes
hippocampus .a 4510 to 4868 12 to 363     Submitted on the opposite strand, also hits gene peyraw, RAB43P1 352/364
(96 %)
21 diff
(94.3 %id)
N23265 nose, olfactory epithelium .a 4536 to 4868 335 to 1       335/338
(99 %)
3 diff
(99.2 %id)
AA557182.
matches multiple genes
breast .a 4538 to 4867 329 to 1     also hits gene peyraw, RAB43P1 329/329
(100 %)
2 diff
(99.4 %id)
AI139116.
matches multiple genes
heart .a 4538 to 4870 333 to 1     also hits gene peyraw 333/333
(100 %)
0 diff
(100 %id)
AI740737.
matches multiple genes
pooled .a 4543 to 4868 326 to 1     also hits gene peyraw 326/326
(100 %)
0 diff
(100 %id)
AA479004.
matches multiple genes
ovarian tumor, ovary .a 4544 to 4868 325 to 1     also hits gene peyraw 325/325
(100 %)
2 diff
(99.4 %id)
AI401086.
matches multiple genes
Prostate .a 4549 to 4868 320 to 1     also hits gene peyraw, RAB43P1 320/320
(100 %)
1 diff
(99.7 %id)
R29670.
matches multiple genes
  .a 4550 to 4801 1 to 240     also hits gene peyraw 240/251
(95 %)
16 diff
(93.7 %id)
AW572643.
matches multiple genes
lymph node, lymphoma, follicular mixed small and largecell .a 4556 to 4868 313 to 1     also hits gene peyraw 313/313
(100 %)
0 diff
(100 %id)
H55841.
matches multiple genes
liver and spleen .a 4565 to 4855 1 to 290   fully sequenced, also hits gene peyraw, RAB43P1 290/290
(100 %)
9 diff
(96.9 %id)
AI937413.
matches multiple genes
anaplastic oligodendroglioma, brain .a 4577 to 4868 292 to 1     also hits gene peyraw 292/292
(100 %)
0 diff
(100 %id)
AI580675.
matches multiple genes
poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 4578 to 4867 290 to 1     also hits gene peyraw 290/290
(100 %)
0 diff
(100 %id)
AA639476.
matches multiple genes
colon, colon tumor RER+ .a 4583 to 4865 283 to 1     also hits gene peyraw 283/283
(100 %)
2 diff
(99.3 %id)
AA505526.
matches multiple genes
breast .a 4587 to 4868 282 to 1     also hits gene peyraw 282/282
(100 %)
2 diff
(99.3 %id)
AA677624.
matches multiple genes
liver and spleen .a 4590 to 4865 274 to 1     also hits gene peyraw 274/274
(100 %)
2 diff
(99.3 %id)
AI022154.
matches multiple genes
liver and spleen .a 4590 to 4865 276 to 1     also hits gene peyraw, RAB43P1 276/276
(100 %)
1 diff
(99.7 %id)
AA156078   .a 4594 to 4874 1 to 280   tiling clone,   280/280
(100 %)
1 diff
(99.7 %id)
AA777830.
matches multiple genes
liver and spleen .a 4598 to 4815 216 to 1     also hits gene peyraw, RAB43P1 216/216
(100 %)
3 diff
(98.7 %id)
AA677436.
matches multiple genes
liver and spleen .a 4598 to 4865 268 to 1     also hits gene peyraw 268/268
(100 %)
0 diff
(100 %id)
AI560336.
matches multiple genes
anaplastic oligodendroglioma, brain .a 4600 to 4868 271 to 1     also hits gene peyraw, RAB43P1 271/272
(99 %)
2 diff
(99.3 %id)
AA155993.
matches multiple genes
  .a 4614 to 4851 237 to 1     also hits gene peyraw, RAB43P1 237/237
(100 %)
1 diff
(99.6 %id)
H55750.
matches multiple genes
liver and spleen .a 4634 to 4868 235 to 1   fully sequenced, also hits gene peyraw, RAB43P1 235/235
(100 %)
3 diff
(98.8 %id)
D60173.
matches multiple genes
  .a 4657 to 4868 1 to 212     also hits gene peyraw 212/212
(100 %)
0 diff
(100 %id)
D81789.
matches multiple genes
brain .a 4657 to 4868 1 to 212     also hits gene peyraw 212/212
(100 %)
4 diff
(98.2 %id)
DB529304.
matches multiple genes
hippocampus .a 4663 to 4868 1 to 206     Submitted on the opposite strand, also hits gene peyraw 206/206
(100 %)
2 diff
(99.1 %id)
AW337681.
matches multiple genes
lung, two pooled squamous cell carcinomas .a 4670 to 4868 200 to 2     also hits gene peyraw 199/201
(99 %)
0 diff
(100 %id)
AW075243.
matches multiple genes
anaplastic oligodendroglioma, brain .a 4683 to 4868 186 to 1     also hits gene peyraw 186/186
(100 %)
0 diff
(100 %id)
BG334260 melanotic melanoma, skin .b 1 to 802 1 to 743   tiling clone,   720/805
(89 %)
41 diff
(95.0 %id)
BE745940 adenocarcinoma cell line, ovary .b 20 to 802 1 to 779   tiling clone,   779/1061
(73 %)
22 diff
(98.0 %id)
BE745132 adenocarcinoma cell line, ovary .b 21 to 743 1 to 725   tiling clone,   725/756
(95 %)
11 diff
(98.6 %id)
BM012169 brain, neuroblastoma, cell line .b 269 to 889 1 to 633   tiling clone,   631/698
(90 %)
32 diff
(95.5 %id)
TI_59381371   .b 269 to 889 98 to 730       631/698
(90 %)
32 diff
(95.5 %id)
BF934579 nervous_tumor .b 824 to 1166 1 to 343   tiling clone, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 343/344
(99 %)
2 diff
(99.5 %id)
BQ231767 embryonal carcinoma, cell line, testis .c 1 to 882 1 to 891   tiling clone,   891/892
(99 %)
13 diff
(98.6 %id)
BG281114 melanotic melanoma, skin .c 63 to 575 1 to 524       520/787
(66 %)
23 diff
(97.1 %id)
BG282120 melanotic melanoma, skin .c 63 to 900 1 to 833       833/833
(100 %)
10 diff
(98.8 %id)
BM193451 leukopheresis .c 76 to 505 1 to 428       428/441
(97 %)
12 diff
(97.3 %id)
BE275499 melanotic melanoma, skin .c 83 to 736 1 to 646       646/673
(95 %)
13 diff
(98.1 %id)
BE386353 melanotic melanoma, skin .c 83 to 670 1 to 589       589/589
(100 %)
3 diff
(99.5 %id)
BE384136 melanotic melanoma, skin .c 84 to 736 1 to 649       649/669
(97 %)
11 diff
(98.4 %id)
BC019849 Testis, embryonal carcinoma .c 108 to 1865 1 to 1758 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1758/1759
(99 %)
1 diff
(100.0 %id)
NM_020701.2   .c 108 to 1866 1 to 1759 exact RefSeq, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1759/1759
(100 %)
1 diff
(100.0 %id)
DB456453 testis .c 166 to 670 1 to 505       505/505
(100 %)
1 diff
(99.9 %id)
BQ949416 large cell carcinoma, lung .c 200 to 981 1 to 788       788/910
(86 %)
10 diff
(99.0 %id)
AL702497 human skeletal muscle .c 205 to 693 1 to 489       489/489
(100 %)
1 diff
(99.8 %id)
BX423484 brain, fetal brain .c 206 to 1158 1 to 945       945/988
(95 %)
13 diff
(98.7 %id)
BX461073 brain, fetal brain .c 206 to 1228 1 to 1007 E27X K56X K92*     1007/1018
(98 %)
25 diff
(97.6 %id)
BG701408 brain, hippocampus .c 209 to 918 1 to 716       716/820
(87 %)
18 diff
(97.9 %id)
BF025826 melanotic melanoma, skin .c 214 to 956 1 to 733       733/778
(94 %)
23 diff
(97.1 %id)
BE729840 melanotic melanoma, skin .c 215 to 942 1 to 724       724/727
(99 %)
6 diff
(99.2 %id)
BQ054288 blood, natural killer cells, cell line .c 216 to 1250 1 to 1045 E219R E220G E221G S222V D223X ...     1045/1048
(99 %)
10 diff
(99.1 %id)
BF975779 B-cells, primary B-cells from tonsils (cell line) .c 218 to 639 1 to 428       427/428
(99 %)
8 diff
(98.2 %id)
BG686210 B-cells, primary B-cells from tonsils (cell line) .c 218 to 993 1 to 777       777/777
(100 %)
6 diff
(99.3 %id)
BF973192 leiomyosarcoma cell line, uterus .c 221 to 910 1 to 692       690/692
(99 %)
9 diff
(98.7 %id)
BQ053774 blood, natural killer cells, cell line .c 221 to 1159 1 to 954       952/1006
(94 %)
19 diff
(98.2 %id)
BQ068663 brain, neuroblastoma, cell line .c 223 to 1196 1 to 989 E203G E204K E205G E206G E207G ...     987/997
(98 %)
34 diff
(96.6 %id)
BQ051942 blood, natural killer cells, cell line .c 223 to 1220 1 to 1002 K230E G231R G232R D233G D234R ...     1002/1006
(99 %)
14 diff
(98.7 %id)
BE387424 melanotic melanoma, skin .c 230 to 938 1 to 708       708/712
(99 %)
12 diff
(98.4 %id)
BG684965 B-cells, primary B-cells from tonsils (cell line) .c 230 to 898 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
BG821610 adenocarcinoma cell line, colon .c 231 to 901 1 to 672       672/673
(99 %)
4 diff
(99.5 %id)
CF146594 CNCAP(3)T-225 cell line, Prostate .c 231 to 462 8 to 239       232/247
(93 %)
17 diff
(93.2 %id)
CR614909 placenta .c 233 to 1402 1 to 1170 exact     1170/1170
(100 %)
0 diff
(100 %id)
AL541423 placenta .c 233 to 767 1 to 534   fully sequenced,   534/534
(100 %)
5 diff
(99.1 %id)
BQ227078 large cell carcinoma, lung .c 234 to 1031 1 to 801       801/884
(90 %)
5 diff
(99.5 %id)
CB991665 placenta, pre-eclamptic placenta .c 236 to 981 28 to 774       749/816
(91 %)
25 diff
(97.0 %id)
BE276023 melanotic melanoma, skin .c 237 to 1073 25 to 861       836/896
(93 %)
26 diff
(97.1 %id)
BE387185 melanotic melanoma, skin .c 237 to 916 22 to 700       679/700
(97 %)
8 diff
(98.9 %id)
BE730246 melanotic melanoma, skin .c 237 to 1067 29 to 859       831/941
(88 %)
22 diff
(97.7 %id)
BE277863 melanotic melanoma, skin .c 238 to 945 14 to 717       704/765
(92 %)
20 diff
(97.4 %id)
BE276701 melanotic melanoma, skin .c 238 to 600 25 to 386       362/386
(93 %)
6 diff
(98.5 %id)
BE387350 melanotic melanoma, skin .c 239 to 726 32 to 520       489/523
(93 %)
7 diff
(98.7 %id)
BU855939 ovary, teratocarcinoma, cell line .c 239 to 1124 1 to 904       896/943
(95 %)
28 diff
(97.1 %id)
BU931163 ovary, teratocarcinoma, cell line .c 239 to 982 1 to 753       749/951
(78 %)
25 diff
(97.4 %id)
CN349147 embryonic stem cells, DMSO-treated H9 cellline .c 241 to 948 1 to 708       708/708
(100 %)
3 diff
(99.6 %id)
BE727470 melanotic melanoma, skin .c 241 to 981 1 to 739       739/857
(86 %)
23 diff
(97.4 %id)
AJ708882 heart .c 242 to 505 1 to 264       264/264
(100 %)
2 diff
(99.3 %id)
BE277168 melanotic melanoma, skin .c 242 to 1020 1 to 765       765/800
(95 %)
24 diff
(97.0 %id)
BE747679 adenocarcinoma cell line, ovary .c 242 to 826 40 to 633       486/918
(52 %)
23 diff
(97.5 %id)
DN989570 brain, whole brain .c 242 to 862 1 to 621       621/621
(100 %)
5 diff
(99.2 %id)
BG334501 melanotic melanoma, skin .c 243 to 940 1 to 700       700/981
(71 %)
17 diff
(98.3 %id)
BG425066 Kidney, renal cell adenocarcinoma .c 243 to 975 1 to 732       732/975
(75 %)
25 diff
(97.5 %id)
BX388140   .c 245 to 1086 1 to 844       844/958
(88 %)
10 diff
(99.0 %id)
BE410984 choriocarcinoma, placenta .c 245 to 935 1 to 690       690/753
(91 %)
17 diff
(97.8 %id)
TI_57243088   .c 245 to 1056 69 to 882       814/882
(92 %)
12 diff
(98.7 %id)
BX382998   .c 246 to 1242 1 to 988 E134X D164X E176X K180H L181S ...     988/988
(100 %)
16 diff
(98.4 %id)
BG477922 melanotic melanoma, skin .c 246 to 740 1 to 498       498/724
(68 %)
11 diff
(98.5 %id)
BI918318 brain .c 246 to 1056 1 to 813       813/813
(100 %)
4 diff
(99.6 %id)
BG437446 large cell carcinoma, lung .c 247 to 988 1 to 753       753/880
(85 %)
19 diff
(97.9 %id)
BG683221 brain, neuroblastoma, cell line .c 247 to 818 1 to 574       574/574
(100 %)
4 diff
(99.4 %id)
BQ069929 brain, neuroblastoma, cell line .c 247 to 1068 23 to 847       825/1037
(79 %)
21 diff
(98.0 %id)
CR997818 T-Lymphocytes .c 247 to 1065 1 to 821       821/824
(99 %)
6 diff
(99.3 %id)
CT001846 T-Lymphocytes .c 247 to 1058 1 to 814       814/816
(99 %)
5 diff
(99.4 %id)
BM558956 eye, retinoblastoma .c 248 to 1246 1 to 1017 E225G I251D E252*     1015/1017
(99 %)
24 diff
(97.7 %id)
BQ053990 blood, natural killer cells, cell line .c 248 to 1220 1 to 983 V243G R257P R258K K259E E262G ...     983/1042
(94 %)
27 diff
(97.5 %id)
BU899217 Spleen .c 248 to 981 1 to 735       735/863
(85 %)
9 diff
(99.0 %id)
BQ641848 eye, normal pigmented retinal epithelium .c 248 to 1060 1 to 825       823/927
(88 %)
19 diff
(98.0 %id)
BC004442 Lung, small cell carcinoma .c 249 to 1428 1 to 1180 exact available from MGC, AAA   1180/1180
(100 %)
0 diff
(100 %id)
BF203756 muscle, rhabdomyosarcoma .c 249 to 966 1 to 711       711/944
(75 %)
10 diff
(99.0 %id)
BF304593 muscle, rhabdomyosarcoma .c 249 to 980 1 to 722       722/929
(77 %)
21 diff
(97.8 %id)
BF304917 muscle, rhabdomyosarcoma .c 249 to 981 1 to 741       741/873
(84 %)
19 diff
(97.9 %id)
BG478487 melanotic melanoma, skin .c 249 to 924 1 to 687       683/687
(99 %)
19 diff
(97.3 %id)
BM012076 brain, neuroblastoma, cell line .c 249 to 938 1 to 692       690/692
(99 %)
13 diff
(98.2 %id)
BU180181 ductal carcinoma, cell line, Pancreas .c 249 to 1065 1 to 821       821/887
(92 %)
19 diff
(97.9 %id)
BU174434 ductal carcinoma, cell line, Pancreas .c 249 to 981 1 to 737       737/853
(86 %)
10 diff
(98.9 %id)
BQ689964 ductal carcinoma, cell line, Pancreas .c 249 to 1129 1 to 888       886/888
(99 %)
14 diff
(98.5 %id)
CN349153 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 250 to 883 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
BM465347 eye, retinoblastoma .c 250 to 981 16 to 749       734/964
(76 %)
19 diff
(98.1 %id)
TI_59381273   .c 250 to 938 97 to 787       689/691
(99 %)
12 diff
(98.3 %id)
CT003111 T-Lymphocytes .c 250 to 1105 1 to 859       859/860
(99 %)
8 diff
(99.1 %id)
BG333342 large cell carcinoma, lung .c 251 to 941 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
BQ278701 adenocarcinoma, cell line, breast .c 251 to 981 1 to 731       731/1089
(67 %)
9 diff
(99.2 %id)
BQ052432 blood, natural killer cells, cell line .c 251 to 1175 1 to 932       930/1075
(86 %)
25 diff
(97.7 %id)
BQ896208 brain, neuroblastoma, cell line .c 251 to 981 1 to 732       732/933
(78 %)
6 diff
(99.4 %id)
BU538890 adenocarcinoma, cell line, breast .c 251 to 1134 1 to 885       885/888
(99 %)
7 diff
(99.3 %id)
BU539246 adenocarcinoma, cell line, breast .c 251 to 1108 1 to 862       860/873
(98 %)
9 diff
(99.0 %id)
BU558165 adenocarcinoma, cell line, breast .c 251 to 981 1 to 735       735/943
(77 %)
13 diff
(98.7 %id)
BU857420 adenocarcinoma, cell line, breast .c 251 to 990 1 to 744       744/834
(89 %)
15 diff
(98.3 %id)
BU859626 ovary, teratocarcinoma, cell line .c 251 to 1147 1 to 900       900/901
(99 %)
11 diff
(98.8 %id)
BU955981 adenocarcinoma, cell line, breast .c 251 to 981 1 to 732       732/892
(82 %)
7 diff
(99.3 %id)
BU956914 adenocarcinoma, cell line, breast .c 251 to 1031 1 to 793       791/885
(89 %)
20 diff
(97.8 %id)
CX865691 embryonic stem .c 251 to 974 1 to 724       724/724
(100 %)
0 diff
(100 %id)
CR996143 T-Lymphocytes .c 253 to 932 1 to 680       680/682
(99 %)
1 diff
(99.9 %id)
BE737420 adenocarcinoma, Pancreas .c 255 to 983 34 to 761       728/851
(85 %)
17 diff
(98.1 %id)
CB049536 Prostate .c 257 to 890 1 to 636       634/636
(99 %)
12 diff
(98.2 %id)
BQ931565 eye, normal pigmented retinal epithelium .c 259 to 1081 1 to 828       828/957
(86 %)
28 diff
(97.1 %id)
CR992954 T-Lymphocytes .c 261 to 1204 1 to 942 S276V E277K E278K A279P R280E ...     942/942
(100 %)
9 diff
(99.1 %id)
BF125338 melanotic melanoma, skin .c 263 to 982 1 to 711   AAA   711/917
(77 %)
21 diff
(97.8 %id)
BE781728 eye, retinoblastoma .c 265 to 736 1 to 472       472/473
(99 %)
0 diff
(100 %id)
BE909025 epithelioid carcinoma, Pancreas .c 265 to 864 1 to 600       600/600
(100 %)
0 diff
(100 %id)
BE277542 melanotic melanoma, skin .c 266 to 702 1 to 437       437/439
(99 %)
4 diff
(99.1 %id)
BE391272 endometrium, adenocarcinoma cell line, uterus .c 266 to 898 1 to 631       629/699
(89 %)
12 diff
(98.3 %id)
BE728999 melanotic melanoma, skin .c 266 to 963 1 to 702       702/859
(81 %)
17 diff
(98.1 %id)
BE745002 adenocarcinoma cell line, ovary .c 267 to 1073 1 to 800       800/860
(93 %)
21 diff
(97.6 %id)
BE745757 adenocarcinoma cell line, ovary .c 267 to 1074 1 to 809       807/1115
(72 %)
26 diff
(97.7 %id)
AA356471   .c 268 to 571 1 to 307       307/307
(100 %)
4 diff
(98.7 %id)
BE736848 adenocarcinoma, Pancreas .c 268 to 1068 1 to 792       792/792
(100 %)
17 diff
(97.9 %id)
BE727564 melanotic melanoma, skin .c 268 to 983 1 to 724       724/870
(83 %)
11 diff
(98.8 %id)
BE745920 adenocarcinoma cell line, ovary .c 268 to 1068 1 to 797       797/1032
(77 %)
12 diff
(98.9 %id)
BE271801 adenocarcinoma cell line, ovary .c 269 to 950 1 to 678       678/718
(94 %)
22 diff
(97.0 %id)
BE296627 muscle, rhabdomyosarcoma .c 270 to 884 1 to 616       616/616
(100 %)
4 diff
(99.4 %id)
BX418603 brain, fetal brain .c 271 to 1089 1 to 819       819/819
(100 %)
0 diff
(100 %id)
BE277083 melanotic melanoma, skin .c 274 to 1025 1 to 748       748/748
(100 %)
13 diff
(98.3 %id)
BE384980 melanotic melanoma, skin .c 276 to 978 1 to 703       703/703
(100 %)
17 diff
(97.6 %id)
BE271619 adenocarcinoma cell line, ovary .c 283 to 926 1 to 644       644/1016
(63 %)
3 diff
(99.8 %id)
BE745279 adenocarcinoma cell line, ovary .c 283 to 956 1 to 668       668/735
(90 %)
11 diff
(98.6 %id)
BF312900 brain, neuroblastoma .c 286 to 1023 1 to 738       736/782
(94 %)
20 diff
(97.5 %id)
BF312458 brain, neuroblastoma .c 286 to 1074 1 to 785       785/974
(80 %)
39 diff
(96.0 %id)
BI194911 brain, neuroblastoma .c 286 to 952 1 to 666       666/667
(99 %)
13 diff
(98.1 %id)
BE514846 adenocarcinoma cell line, ovary .c 287 to 940 1 to 654       654/654
(100 %)
2 diff
(99.7 %id)
BF972843 leiomyosarcoma cell line, uterus .c 287 to 1074 1 to 781       781/824
(94 %)
21 diff
(97.5 %id)
BE729972 melanotic melanoma, skin .c 289 to 951 1 to 667       667/760
(87 %)
9 diff
(98.9 %id)
CX759136 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 292 to 947 1 to 656     Submitted on the opposite strand 656/742
(88 %)
21 diff
(97.2 %id)
AL603611.
matches multiple genes
breast cancer .c 295 to 529 1 to 235     also hits gene CBS 235/235
(100 %)
0 diff
(100 %id)
CR995774 T-Lymphocytes .c 301 to 1158 1 to 857       857/860
(99 %)
6 diff
(99.4 %id)
BE256614 eye, retinoblastoma .c 304 to 919 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BE261593 brain, neuroblastoma .c 306 to 879 1 to 574       574/581
(98 %)
1 diff
(99.9 %id)
BQ694259 adipose .c 310 to 930 1 to 621       621/621
(100 %)
0 diff
(100 %id)
AA211646 muscle, skeletal muscle .c 322 to 390 1 to 70       70/70
(100 %)
2 diff
(97.2 %id)
TI_154187974   .c 347 to 1264 101 to 1011       910/1072
(84 %)
20 diff
(98.2 %id)
TI_154188768   .c 347 to 1232 99 to 976       877/1067
(82 %)
23 diff
(97.9 %id)
BQ896171 brain, neuroblastoma, cell line .c 462 to 1380 1 to 926       926/930
(99 %)
22 diff
(97.7 %id)
BF316354 brain, neuroblastoma .c 504 to 1320 1 to 804       786/850
(92 %)
49 diff
(94.3 %id)
BE745169 adenocarcinoma cell line, ovary .c 509 to 1297 1 to 785       785/963
(81 %)
14 diff
(98.6 %id)
BE741820 adenocarcinoma cell line, ovary .c 510 to 1394 1 to 882       882/984
(89 %)
33 diff
(96.7 %id)
TI_149285163   .c 519 to 1419 985 to 91   AAA   895/1081
(82 %)
13 diff
(98.8 %id)
BQ893156 melanotic melanoma, cell line, skin .c 545 to 1368 1 to 833       833/859
(96 %)
10 diff
(98.9 %id)
BU838746 melanotic melanoma, cell line, skin .c 545 to 1335 1 to 800       800/992
(80 %)
18 diff
(98.2 %id)
BU171406 melanotic melanoma, skin .c 565 to 1327 11 to 777       767/848
(90 %)
15 diff
(98.3 %id)
BU526845 epidermoid carcinoma, cell line, lung .c 567 to 1432 1 to 877       877/909
(96 %)
26 diff
(97.2 %id)
BU940107 mixed (pool of 40 RNAs) .c 569 to 1308 1 to 751       751/851
(88 %)
26 diff
(97.0 %id)
AI761808 colon, colon tumor, RER+ .c 674 to 1426 755 to 5       751/756
(99 %)
10 diff
(98.7 %id)
BQ708113 Spleen .c 697 to 1487 1 to 793       793/953
(83 %)
20 diff
(98.0 %id)
AL568900 placenta .c 706 to 1402 698 to 1   fully sequenced,   698/698
(100 %)
19 diff
(97.3 %id)
BE304528 adenocarcinoma cell line, colon .c 712 to 1364 1 to 652       652/652
(100 %)
2 diff
(99.7 %id)
TI_149291634   .c 720 to 1428 786 to 78   AAA   709/709
(100 %)
1 diff
(99.9 %id)
TI_149287637   .c 737 to 1419 759 to 78   AAA   682/1132
(60 %)
8 diff
(99.3 %id)
BM984704 lung .c 741 to 1419 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
BU682080 lung .c 741 to 1428 706 to 19   AAA   688/688
(100 %)
1 diff
(99.9 %id)
BQ932669 eye, normal pigmented retinal epithelium .c 745 to 1512 1 to 776       776/867
(89 %)
16 diff
(98.2 %id)
BQ279137 adenocarcinoma, cell line, breast .c 754 to 1626 1 to 884       884/978
(90 %)
13 diff
(98.7 %id)
AI420857 Prostate .c 756 to 1428 676 to 4       673/678
(99 %)
7 diff
(99.0 %id)
BI092740 cervix .c 779 to 1475 1 to 694       694/694
(100 %)
4 diff
(99.5 %id)
BQ710455 Spleen .c 811 to 1640 1 to 842       842/965
(87 %)
42 diff
(95.7 %id)
BG030695 breast, mammary adenocarcinoma, cell line .c 813 to 1470 1 to 659       659/908
(72 %)
3 diff
(99.7 %id)
AW247894.
matches multiple genes
lung, small cell carcinoma .c 844 to 1428 595 to 11   AAA also hits gene SLC43A1 585/585
(100 %)
0 diff
(100 %id)
BM972927 lung .c 850 to 1419 588 to 19   AAA   570/570
(100 %)
0 diff
(100 %id)
TI_149306676   .c 860 to 1428 672 to 104   AAA   569/959
(59 %)
4 diff
(99.6 %id)
CB851375 lung, Primary Lung Epithelial Cells .c 860 to 1428 587 to 19   AAA   569/577
(98 %)
4 diff
(99.4 %id)
CA432530 cell lines, Chondrosarcoma .c 860 to 1428 587 to 19   AAA   569/577
(98 %)
3 diff
(99.5 %id)
BQ054564 lymph, lymphoma, cell line .c 869 to 1784 1 to 926       926/1018
(90 %)
17 diff
(98.4 %id)
BQ057508 lymph, lymphoma, cell line .c 869 to 1335 1 to 471       471/993
(47 %)
8 diff
(99.2 %id)
BQ059285 lymph, lymphoma, cell line .c 869 to 1805 1 to 948       948/987
(96 %)
28 diff
(97.2 %id)
BQ065977 lymph, lymphoma, cell line .c 869 to 1790 1 to 929       929/990
(93 %)
23 diff
(97.7 %id)
BE270804 Burkitt lymphoma, lymph .c 897 to 1428 1 to 528   fully sequenced, AAA   530/530
(100 %)
6 diff
(98.9 %id)
AI654444 pooled germ cell tumors .c 918 to 1428 526 to 17   AAA   510/510
(100 %)
4 diff
(99.3 %id)
AV716620   .c 926 to 1567 1 to 639       639/686
(93 %)
16 diff
(97.7 %id)
R73991 placenta .c 950 to 1263 1 to 315       315/315
(100 %)
3 diff
(99.1 %id)
BE270985 Burkitt lymphoma, lymph .c 951 to 1380 438 to 1   fully sequenced,   438/438
(100 %)
9 diff
(98.0 %id)
BU173642 melanotic melanoma, cell line, skin .c 974 to 1733 1 to 763       763/863
(88 %)
15 diff
(98.3 %id)
BQ675818 epidermoid carcinoma, cell line, salivary gland .c 974 to 1790 1 to 820       820/836
(98 %)
9 diff
(99.0 %id)
BQ648939 hepatocellular carcinoma, cell line, Liver .c 977 to 1426 487 to 38   AAA Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
BQ647322 hepatocellular carcinoma, cell line, Liver .c 977 to 1426 497 to 48   AAA Submitted on the opposite strand 450/450
(100 %)
0 diff
(100 %id)
AI674346 Prostate .c 980 to 1428 449 to 2       448/454
(98 %)
3 diff
(99.4 %id)
BG683855 brain, neuroblastoma, cell line .c 980 to 1816 839 to 1       839/844
(99 %)
11 diff
(98.7 %id)
AI682394 Prostate .c 982 to 1428 447 to 1       447/447
(100 %)
0 diff
(100 %id)
BG032464 breast, mammary adenocarcinoma, cell line .c 990 to 1725 13 to 755       743/1114
(66 %)
34 diff
(97.0 %id)
AW418814 2 pooled tumors (clear cell type), Kidney .c 1001 to 1501 504 to 4       501/504
(99 %)
0 diff
(100 %id)
BE396232 endometrium, adenocarcinoma cell line, uterus .c 1002 to 1354 1 to 349       349/381
(91 %)
8 diff
(98.0 %id)
BE552209 pooled germ cell tumors .c 1006 to 1428 439 to 17   AAA   423/423
(100 %)
0 diff
(100 %id)
AA976803 pooled germ cell tumors .c 1012 to 1428 416 to 1       416/416
(100 %)
2 diff
(99.6 %id)
BF568377 epithelioid carcinoma cell line, Pancreas .c 1031 to 1811 1 to 781   fully sequenced,   781/781
(100 %)
7 diff
(99.2 %id)
BE550022 carcinoid, lung .c 1040 to 1280 1 to 241     Submitted on the opposite strand 241/241
(100 %)
0 diff
(100 %id)
AW139877   .c 1042 to 1428 404 to 18   AAA   387/397
(97 %)
3 diff
(99.3 %id)
BE898295 adenocarcinoma cell line, ovary .c 1053 to 1694 1 to 640       642/640
(100 %)
4 diff
(99.4 %id)
AW406259 lymph .c 1064 to 1357 1 to 295       295/295
(100 %)
6 diff
(98.0 %id)
BX391872   .c 1069 to 1524 460 to 1       460/619
(74 %)
9 diff
(98.6 %id)
BU942727 mixed (pool of 40 RNAs) .c 1077 to 1427 1 to 351   AAA   351/351
(100 %)
0 diff
(100 %id)
BE859083 Prostate .c 1082 to 1428 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AI695849 Prostate .c 1086 to 1428 343 to 1       343/343
(100 %)
0 diff
(100 %id)
CB049535 Prostate .c 1107 to 1428 345 to 24   AAA   322/322
(100 %)
6 diff
(98.2 %id)
BX389868   .c 1109 to 1524 5 to 419       415/419
(99 %)
6 diff
(98.6 %id)
AW960546   .c 1168 to 1568 1 to 403   AAA   403/403
(100 %)
33 diff
(91.9 %id)
AA303850 aorta .c 1173 to 1550 1 to 380       380/380
(100 %)
6 diff
(98.5 %id)
BF569152 epithelioid carcinoma cell line, Pancreas .c 1323 to 1832 550 to 40   fully sequenced,   511/550
(92 %)
8 diff
(98.6 %id)
AW150689 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1409 to 1704 296 to 1       296/296
(100 %)
0 diff
(100 %id)
C16837   .c 1488 to 1701 1 to 215       215/215
(100 %)
5 diff
(97.7 %id)
AA211599 muscle, skeletal muscle .c 1534 to 1865 334 to 2       333/334
(99 %)
0 diff
(100 %id)
BI560477 testis .d 1 to 699 1 to 699   tiling clone,   699/700
(99 %)
10 diff
(98.6 %id)
TI_44349452   .d 6 to 699 92 to 785       694/786
(88 %)
11 diff
(98.7 %id)
BX490447   .d 28 to 627 1 to 600       600/600
(100 %)
2 diff
(99.7 %id)
BG477973 melanotic melanoma, skin .d 33 to 699 1 to 677       675/697
(96 %)
35 diff
(95.0 %id)
BG385953 adenocarcinoma cell line, colon .d 41 to 703 1 to 661       661/729
(90 %)
17 diff
(97.7 %id)
BG469961 adenocarcinoma cell line, colon .d 41 to 658 1 to 619       619/620
(99 %)
10 diff
(98.4 %id)
BG469507 adenocarcinoma cell line, colon .d 58 to 595 1 to 539       539/539
(100 %)
3 diff
(99.5 %id)
BM917924 blood, natural killer cells, cell line .d 59 to 629 17 to 587       571/1125
(50 %)
15 diff
(98.7 %id)
BF683325 leiomyosarcoma cell line, uterus .d 61 to 672 1 to 607       607/940
(64 %)
8 diff
(99.2 %id)
BF685965 leiomyosarcoma cell line, uterus .d 61 to 703 1 to 636       636/897
(70 %)
25 diff
(97.3 %id)
BG337497 leiomyosarcoma cell line, uterus .d 61 to 703 1 to 643       643/645
(99 %)
8 diff
(98.8 %id)
BG831204 epithelioid carcinoma cell line, Pancreas .d 66 to 699 1 to 633       633/633
(100 %)
1 diff
(99.9 %id)
BI161178 epithelioid carcinoma cell line, Pancreas .d 66 to 697 1 to 633       633/633
(100 %)
19 diff
(97.0 %id)
BE395478 endometrium, adenocarcinoma cell line, uterus .d 71 to 690 1 to 620       620/667
(92 %)
7 diff
(99.0 %id)
BQ876902 ductal carcinoma, cell line, Pancreas .d 73 to 602 1 to 530       530/956
(55 %)
5 diff
(99.5 %id)
BM921392 pooled brain, lung, testis .d 77 to 699 8 to 630       623/1098
(56 %)
8 diff
(99.3 %id)
BE891629 melanotic melanoma, skin .d 80 to 690 1 to 613       613/613
(100 %)
3 diff
(99.6 %id)
BG754111 B-cells, primary B-cells from tonsils (cell line) .d 84 to 688 1 to 605       605/605
(100 %)
1 diff
(99.9 %id)
CN349142 embryonic stem cells, cell lines H1, H7, andH9 .d 85 to 616 1 to 530       530/530
(100 %)
3 diff
(99.5 %id)
BG476613 melanotic melanoma, skin .d 86 to 660 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
AW247282.
matches multiple genes
lung, small cell carcinoma .d 87 to 692 8 to 613     also hits gene SLC43A1 606/613
(98 %)
6 diff
(99.1 %id)
BG682881 brain, neuroblastoma, cell line .d 87 to 703 1 to 621       621/854
(72 %)
12 diff
(98.6 %id)
BU500987 eye, normal pigmented retinal epithelium .d 88 to 660 1 to 579       579/1097
(52 %)
17 diff
(98.5 %id)
BF310973 brain, neuroblastoma .d 89 to 697 1 to 613       613/919
(66 %)
18 diff
(98.1 %id)
BG282409 melanotic melanoma, skin .d 89 to 691 1 to 610       610/1144
(53 %)
19 diff
(98.4 %id)
BG334383 melanotic melanoma, skin .d 89 to 703 1 to 616       616/893
(68 %)
14 diff
(98.5 %id)
BG826198 muscle, rhabdomyosarcoma .d 89 to 694 1 to 605       605/608
(99 %)
24 diff
(96.1 %id)
BM050302 eye, normal pigmented retinal epithelium .d 89 to 699 1 to 616       616/621
(99 %)
17 diff
(97.3 %id)
BM050287 eye, normal pigmented retinal epithelium .d 91 to 692 1 to 599       599/601
(99 %)
5 diff
(99.2 %id)
CN349146 embryonic stem cells, DMSO-treated H9 cellline .d 93 to 687 1 to 595       595/595
(100 %)
0 diff
(100 %id)
BG752246 eye, normal pigmented retinal epithelium .d 94 to 682 1 to 590       590/590
(100 %)
5 diff
(99.2 %id)
BQ069284 brain, neuroblastoma, cell line .d 97 to 1084 1 to 992 R212X D213R Q214S G230R A250S tiling clone,   992/995
(99 %)
20 diff
(98.0 %id)
BF997916 placenta_normal .d 98 to 693 1 to 595       595/605
(98 %)
10 diff
(98.4 %id)
BF999519 placenta_normal .d 98 to 664 1 to 566       566/566
(100 %)
5 diff
(99.2 %id)
CX868378 embryonic stem .d 100 to 590 1 to 491       491/491
(100 %)
0 diff
(100 %id)
BG171683 hypernephroma, cell line, Kidney .d 105 to 699 1 to 596       596/603
(98 %)
7 diff
(98.9 %id)
BE395690 endometrium, adenocarcinoma cell line, uterus .d 107 to 679 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
BE304363 adenocarcinoma cell line, colon .d 108 to 685 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
BE384934 melanotic melanoma, skin .d 109 to 676 1 to 570       570/574
(99 %)
5 diff
(99.2 %id)
CD557197 testis .d 109 to 698 1 to 595       595/806
(73 %)
6 diff
(99.3 %id)
BE407856 choriocarcinoma, placenta .d 111 to 703 1 to 617       589/755
(78 %)
39 diff
(94.9 %id)
CN349141 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 112 to 667 13 to 572       556/572
(97 %)
7 diff
(98.8 %id)
BF973740 leiomyosarcoma cell line, uterus .d 115 to 691 1 to 585       585/960
(60 %)
15 diff
(98.5 %id)
BE262064 brain, neuroblastoma .d 146 to 679 1 to 534       534/656
(81 %)
1 diff
(99.9 %id)
BE562638 endometrium, adenocarcinoma cell line, uterus .d 419 to 1108 1 to 686   tiling clone,   686/924
(74 %)
9 diff
(99.1 %id)
BG758187 B-cells, primary B-cells from tonsils (cell line) .d 463 to 1181 1 to 783       546/784
(69 %)
39 diff
(95.1 %id)
BX423483 brain, fetal brain .d 921 to 1875 954 to 1       954/957
(99 %)
34 diff
(96.5 %id)
BM988611 lung, Metastatic Chondrosarcoma .d 952 to 1725 763 to 1       763/797
(95 %)
16 diff
(98.0 %id)
BG576162 breast, mammary adenocarcinoma, cell line .d 968 to 1642 29 to 703       675/703
(96 %)
6 diff
(99.2 %id)
BG684004 B-cells, primary B-cells from tonsils (cell line) .d 987 to 1704 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
BQ720474 sympathetic trunk .d 994 to 1694 1 to 715       715/990
(72 %)
29 diff
(97.1 %id)
BG822975 adenocarcinoma cell line, colon .d 996 to 1727 1 to 741       741/768
(96 %)
15 diff
(98.1 %id)
BU154744 leiomyosarcoma, uterus .d 1031 to 1849 1 to 824   tiling clone,   824/879
(93 %)
9 diff
(99.0 %id)
BQ052801 blood, natural killer cells, cell line .d 1050 to 1709 1 to 660   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 660/661
(99 %)
1 diff
(99.9 %id)
BQ053711 blood, natural killer cells, cell line .d 1050 to 1716 1 to 667       667/677
(98 %)
8 diff
(98.9 %id)
BI195009 brain, neuroblastoma .d 1062 to 1726 1 to 657       657/658
(99 %)
12 diff
(98.2 %id)
BG683591 brain, neuroblastoma, cell line .d 1088 to 1636 549 to 1       549/549
(100 %)
2 diff
(99.7 %id)
BU145397 ductal carcinoma, cell line, Pancreas .d 1127 to 1709 1 to 583   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 583/584
(99 %)
1 diff
(99.9 %id)
AV703565 adrenal gland .d 1173 to 1707 10 to 545   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 536/545
(98 %)
6 diff
(98.9 %id)
AI890774 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 1194 to 1709 518 to 4       515/518
(99 %)
0 diff
(100 %id)
AI281394 follicular lymphoma, lymph node .d 1213 to 1701 489 to 1       489/489
(100 %)
0 diff
(100 %id)
AA532673 normal prostatic epithelial cells, Prostate .d 1254 to 1728 8 to 483       476/486
(97 %)
22 diff
(95.5 %id)
BM014331 breast, mammary adenocarcinoma, cell line .d 1254 to 1772 1 to 519       519/705
(73 %)
12 diff
(98.3 %id)
TI_59392321   .d 1254 to 1772 87 to 605       519/759
(68 %)
12 diff
(98.5 %id)
H99962 melanocyte .d 1265 to 1709 449 to 2       448/449
(99 %)
0 diff
(100 %id)
BX413375 brain, fetal brain .d 1275 to 1905 640 to 8       633/920
(68 %)
0 diff
(100 %id)
BE049544 adenocarcinoma, Pancreas .d 1301 to 1709 412 to 4       409/412
(99 %)
0 diff
(100 %id)
AW194267 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 1304 to 1709 409 to 4       406/409
(99 %)
0 diff
(100 %id)
DA621676 Kidney .d 1306 to 1634 2 to 331   capped   330/332
(99 %)
2 diff
(99.4 %id)
BG370201 adenocarcinoma, Pancreas .d 1335 to 1709 378 to 4       375/378
(99 %)
0 diff
(100 %id)
AI453233 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 1367 to 1712 346 to 1       346/346
(100 %)
0 diff
(100 %id)
DB521869 testis .d 1421 to 1909 1 to 489     Submitted on the opposite strand 489/489
(100 %)
2 diff
(99.6 %id)
H29851 brain .d 1455 to 1915 467 to 1       467/468
(99 %)
17 diff
(96.4 %id)
BX331125   .d 1493 to 1913 425 to 1     Submitted on the opposite strand 425/1084
(39 %)
22 diff
(98.0 %id)
AI190673 heart .d 1542 to 1910 369 to 1       369/369
(100 %)
1 diff
(99.8 %id)
BF475618 Prostate .d 1609 to 1918 316 to 7       310/316
(98 %)
0 diff
(100 %id)
AA552088 colon .d 1679 to 1915 253 to 16   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 238/238
(100 %)
4 diff
(98.4 %id)
AI863733 2 pooled tumors (clear cell type), Kidney .d 1679 to 1918 240 to 1   tiling clone,   240/345
(69 %)
1 diff
(99.8 %id)
AK024035   .d 1726 to 3685 1 to 1960   tiling clone, available from FLJ,   1960/1960
(100 %)
0 diff
(100 %id)
AU143205   .d 1727 to 2498 2 to 772   capped   771/771
(100 %)
8 diff
(99.0 %id)
AA976416 2 pooled tumors (clear cell type), Kidney .d 1733 to 1893 189 to 28       162/189
(85 %)
14 diff
(92.6 %id)
AI968119 pooled germ cell tumors .d 1739 to 1915 189 to 13   AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 177/177
(100 %)
1 diff
(99.5 %id)
BF528899 anaplastic oligodendroglioma with 1p/19qloss, brain .d 1813 to 2511 1 to 701       701/701
(100 %)
5 diff
(99.3 %id)
CX753557 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 1981 to 2710 1 to 730     Submitted on the opposite strand 730/730
(100 %)
0 diff
(100 %id)
BX442604 brain, fetal brain .d 2655 to 3631 972 to 1       972/1064
(91 %)
74 diff
(93.1 %id)
BI255440 cervical carcinoma cell line, cervix .d 2693 to 3458 1 to 763       763/767
(99 %)
11 diff
(98.6 %id)
CR995635 T-Lymphocytes .d 2697 to 3135 1 to 440       440/441
(99 %)
4 diff
(99.1 %id)
BI860497 breast, mammary adenocarcinoma, cell line .d 2702 to 3146 32 to 474       443/474
(93 %)
6 diff
(98.8 %id)
TI_57189454   .d 2702 to 3146 83 to 525       443/475
(93 %)
6 diff
(98.8 %id)
BG479015 choriocarcinoma, placenta .d 2722 to 3577 1 to 855       855/856
(99 %)
8 diff
(99.1 %id)
DB320422 Kidney .d 3123 to 3685 563 to 1       563/567
(99 %)
0 diff
(100 %id)
AU160338   .d 3152 to 3685 530 to 1       530/531
(99 %)
11 diff
(98.0 %id)
AI860911 anaplastic oligodendroglioma, brain .d 3226 to 3685 461 to 1       461/461
(100 %)
3 diff
(99.4 %id)
AA835218 Pancreas .d 3410 to 3686 281 to 5   tiling clone,   277/281
(98 %)
0 diff
(100 %id)
AI202059 anaplastic oligodendroglioma, brain .d 3438 to 3600 163 to 1       163/163
(100 %)
0 diff
(100 %id)
BX101105 placenta .e 1 to 741 1 to 740 exact tiling clone,   740/745
(99 %)
2 diff
(99.8 %id)
N42008.
matches multiple genes
placenta .e 60 to 393 1 to 332   tiling clone, also hits gene RAB43P1 332/336
(98 %)
9 diff
(97.4 %id)
N30287.
matches multiple genes
placenta .e 491 to 1091 596 to 1   tiling clone, also hits gene RAB43P1 596/600
(99 %)
13 diff
(97.9 %id)
DB220260 trachea .f 1 to 572 2 to 574   tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
BI910542 leukocyte .f 12 to 804 1 to 822       822/822
(100 %)
27 diff
(96.8 %id)
TI_57236085   .f 12 to 804 34 to 855       822/855
(96 %)
15 diff
(98.3 %id)
CR620019 fetal liver .f 14 to 1513 1 to 1500 exact tiling clone,   1500/1500
(100 %)
0 diff
(100 %id)
AL532276.
matches multiple genes
brain, fetal liver, Liver, neuroblastoma cells .f 14 to 1001 1 to 973 R175K A177G L188C F189S S190A ...   also hits gene rasuma 973/987
(98 %)
23 diff
(97.7 %id)
CB995331 placenta, pre-eclamptic placenta .f 21 to 459 21 to 459       439/480
(91 %)
6 diff
(98.8 %id)
AY166852 brain .f 22 to 1559 1 to 1538 exact tiling clone,   1538/1538
(100 %)
1 diff
(100.0 %id)
NM_198490.1   .f 28 to 4474 1 to 4447 exact RefSeq,   4447/4447
(100 %)
6 diff
(99.9 %id)
CN482316 eye .f 97 to 172 1 to 76       76/76
(100 %)
2 diff
(97.4 %id)
BG751105 eye, normal pigmented retinal epithelium .f 163 to 980 1 to 822 T178R E179S L180S I181S M182C ...     822/825
(99 %)
10 diff
(98.8 %id)
BC062319 Eye, normal, pigmented retinal epithelium .f 164 to 1557 1 to 1394 exact available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1394/1394
(100 %)
1 diff
(100.0 %id)
DA327155 hippocampus .f 173 to 736 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA736002.
matches multiple genes
  .f 173 to 967 2 to 793 D134X Q147X L174* capped also hits gene peyraw, RAB43P1 792/798
(99 %)
5 diff
(99.4 %id)
DB287604 uterus .f 173 to 749 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA108955 cerebellum .f 185 to 728 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA109779 cerebellum .f 187 to 723 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DA216330 brain .f 187 to 713 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA246123 brain .f 187 to 738 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DB130734 thymus .f 187 to 729 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB139457 thymus .f 187 to 727 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DB288761 uterus .f 189 to 734 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
AK291014   .f 190 to 1174 1 to 985 exact     985/985
(100 %)
1 diff
(99.9 %id)
DA721812   .f 191 to 760 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB185674 liver, tumor tissue .f 191 to 761 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB225514 trachea .f 191 to 738 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
BG900126 cartilage .f 193 to 496 79 to 383       305/319
(95 %)
5 diff
(98.5 %id)
D45418 pancreatic islet .f 206 to 978 1 to 767 G5R P8G G9P D10G P11R ...     767/767
(100 %)
6 diff
(99.3 %id)
DB231401 trachea .f 213 to 537 2 to 326   capped   325/325
(100 %)
0 diff
(100 %id)
CN293338 embryonic stem cells, DMSO-treated H9 cellline .f 215 to 330 1 to 116       116/116
(100 %)
0 diff
(100 %id)
CR746731 duodenal adenocarcinoma, cell line, small intestine .f 231 to 730 5 to 504       500/504
(99 %)
6 diff
(98.9 %id)
BM806979 duodenal adenocarcinoma, cell line, small intestine .f 245 to 1056 1 to 829 W208X G209X C210L G211R available from MGC,   829/1054
(78 %)
25 diff
(97.7 %id)
BG034182 breast, mammary adenocarcinoma, cell line .f 260 to 1031 1 to 766 A2G G64A K65S R66G V67S ...     766/914
(83 %)
34 diff
(96.3 %id)
DB002048 breast, tumor tissue .f 278 to 833 2 to 562   capped   561/561
(100 %)
5 diff
(99.2 %id)
DA112088 cerebellum .f 281 to 832 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BX471509   .f 284 to 696 1 to 413       413/413
(100 %)
1 diff
(99.8 %id)
CN349145 embryonic stem cells, DMSO-treated H9 cellline .f 294 to 858 1 to 566       566/566
(100 %)
1 diff
(99.9 %id)
DA092157.
matches multiple genes
cerebellum .f 391 to 926 2 to 537   tiling clone, capped also hits gene rasuma 536/536
(100 %)
1 diff
(99.9 %id)
BF872982.
matches multiple genes
lung_tumor .f 420 to 849 1 to 432     also hits gene rasuma 432/432
(100 %)
14 diff
(96.8 %id)
DB163682 thymus .f 430 to 1006 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
AU153095.
matches multiple genes
  .f 4087 to 4474 391 to 1   tiling clone, also hits gene peyraw, RAB43P1 391/438
(89 %)
6 diff
(98.7 %id)
BF974848 B-cells, primary B-cells from tonsils (cell line) .g 1 to 765 1 to 761 Q186P P187A P195A V198F H199I ... tiling clone,   759/763
(99 %)
13 diff
(98.3 %id)
BF568444 epithelioid carcinoma cell line, Pancreas .g 262 to 1012 1 to 751   tiling clone, fully sequenced,   751/751
(100 %)
4 diff
(99.5 %id)
T59557 ovary .g 452 to 745 1 to 300       300/385
(77 %)
6 diff
(98.5 %id)
BF569075 epithelioid carcinoma cell line, Pancreas .g 462 to 984 523 to 1   tiling clone, fully sequenced,   523/523
(100 %)
5 diff
(99.1 %id)
T59511 ovary .g 944 to 1323 379 to 1   tiling clone,   379/379
(100 %)
5 diff
(98.7 %id)
BI906034 leukocyte .h 459 to 640 532 to 723 G3W G13W R14A R16P A17S ... tiling clone,   723/1129
(64 %)
43 diff
(96.2 %id)
TI_57231462   .h 459 to 640 567 to 758 G3W G13W R14A R16P A17S ... AAA   728/1138
(63 %)
28 diff
(97.6 %id)
DA008447 adipose .i 1 to 560 2 to 561 exact tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
DA316067 hippocampus .i 5 to 537 2 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
DA757569   .j 1 to 454 2 to 456   tiling clone, capped   455/455
(100 %)
1 diff
(99.8 %id)
DA317502 hippocampus .j 21 to 569 2 to 550 exact tiling clone, capped   549/549
(100 %)
1 diff
(99.9 %id)
DA103180 cerebellum .k 1 to 541 2 to 542 exact tiling clone, capped   541/541
(100 %)
0 diff
(100 %id)
BX331971.
matches multiple genes
Neuroblastoma Cot 25-normalized .l 1 to 895 1 to 905 A2X G3Q P4G G5R P6G ...   also hits gene rasuma 905/905
(100 %)
25 diff
(97.3 %id)
CR596493 Neuroblastoma Cot 25-normalized .l 2 to 1628 1 to 1627 exact tiling clone,   1627/1627
(100 %)
0 diff
(100 %id)
DB139947 thymus .l 168 to 700 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
BC004122 Ovary, adenocarcinoma .m 1 to 1193 1 to 1193 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (19/20 A in genome downstream of last aligned base) 1193/1194
(99 %)
1 diff
(100.0 %id)
BE745711 adenocarcinoma cell line, ovary .m 136 to 642 149 to 657       509/657
(77 %)
8 diff
(98.8 %id)
BG478090 melanotic melanoma, skin .n 1 to 630 1 to 629 exact tiling clone,   629/629
(100 %)
4 diff
(99.4 %id)
BE386287 melanotic melanoma, skin .n 19 to 712 1 to 686 exact     686/689
(99 %)
14 diff
(98.0 %id)
BE274413 melanotic melanoma, skin .n 21 to 740 1 to 719 exact tiling clone,   719/892
(80 %)
7 diff
(99.3 %id)
BE727646 melanotic melanoma, skin .n 21 to 677 1 to 657 exact     657/966
(68 %)
3 diff
(99.7 %id)
BF026128 melanotic melanoma, skin .n 21 to 740 1 to 724 exact tiling clone,   724/797
(90 %)
14 diff
(98.3 %id)
BE728499 melanotic melanoma, skin .n 22 to 735 1 to 714 N4D M9* tiling clone,   714/885
(80 %)
18 diff
(98.0 %id)
CN414584 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 217 to 448 1 to 232       232/232
(100 %)
9 diff
(96.2 %id)
DA339537 hippocampus .o 1 to 582 2 to 583 Q112R tiling clone, capped   582/582
(100 %)
1 diff
(99.9 %id)
AK128345 thymus .p 1 to 4271 1 to 4272 exact tiling clone, available from FLJ,   4272/4272
(100 %)
7 diff
(99.9 %id)
DB150237 thymus .p 2 to 591 2 to 591 exact capped   590/590
(100 %)
0 diff
(100 %id)
DB346062 thymus .p 3725 to 4271 547 to 1       547/547
(100 %)
0 diff
(100 %id)
BM561438 blood, natural killer cells, cell line .q 1 to 978 4 to 988 P2A K8S Y9T F10X tiling clone,   985/1064
(92 %)
37 diff
(96.6 %id)
BQ051782 blood, natural killer cells, cell line .q 1 to 1026 16 to 1049 P2A F10X G11W A12S A13S ... tiling clone,   1034/1049
(98 %)
28 diff
(97.4 %id)
AI133241 Liver .r-u 1 to 596 596 to 1 exact tiling clone,   596/601
(99 %)
0 diff
(100 %id)
DB241560 trachea .s 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
1 diff
(99.9 %id)
DB154623 thymus .t 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
0 diff
(100 %id)
AW391392 stomach .u-u 1 to 361 17 to 377 E14K L36* tiling clone,   361/397
(90 %)
10 diff
(97.5 %id)
BC007409 Ovary, adenocarcinoma Gene ISY1andRAB43, variant not shown       available from MGC, AAA This clone was ignored    
BE070784 breast Gene ISY1andRAB43, variant not shown         This clone was ignored    
BI063275 uterus_tumor Gene ISY1andRAB43, variant not shown         This clone was ignored    
AW960986   Gene ISY1andRAB43, variant not shown         This clone was ignored    
AW818199 stomach Gene ISY1andRAB43, variant not shown         This clone was ignored    
AA653728.
matches multiple genes
normal prostate, Prostate Gene RAB43P1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene RAB43P1    
AA653728.
matches multiple genes
normal prostate, Prostate Gene ISY1andRAB43, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene RAB43P1    
AA864976.
matches multiple genes
Kidney Gene RAB43P1, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene RAB43P1    
AA864976.
matches multiple genes
Kidney Gene ISY1andRAB43, variant not shown         Suspected internal deletion, this clone was ignored, also hits gene RAB43P1    
AW452812.
matches multiple genes
  Gene rasuma, variant not shown       AAA Suspected internal deletion, this clone was ignored, also hits gene rasuma    
AW452812.
matches multiple genes
  Gene ISY1andRAB43, variant not shown       AAA Suspected internal deletion, this clone was ignored, also hits gene rasuma    
DB313284 tongue, tumor tissue Gene ISY1andRAB43, variant not shown         This clone was ignored    
DA434159 tongue, tumor tissue Gene ISY1andRAB43, variant not shown       capped This clone was ignored    
BE206467 adenocarcinoma cell line, ovary Gene ISY1andRAB43, variant not shown         This clone was ignored    
BE207652 adenocarcinoma cell line, ovary Gene ISY1andRAB43, variant not shown         This clone was ignored    
BE615945 adenocarcinoma, Pancreas Gene ISY1andRAB43, variant not shown         Suspected internal deletion, this clone was ignored    
BE385060 melanotic melanoma, skin Gene ISY1andRAB43, variant not shown         This clone was ignored    
BE514550 adenocarcinoma cell line, ovary Gene ISY1andRAB43, variant not shown         This clone was ignored    
BU177928 melanotic melanoma, cell line, skin Gene ISY1andRAB43, variant not shown         This clone was ignored    
BQ669753 epidermoid carcinoma, cell line, salivary gland Gene ISY1andRAB43, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r-u, .s, .t, .u-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C